Skip to main content
Back

Anxiety Disorders: Pathophysiology, Clinical Manifestations, and Management

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

Anxiety Disorders

Introduction to Anxiety

Anxiety is a common psychological response to stress, characterized by feelings of mental uneasiness, apprehension, and helplessness. It is often related to an impending or actual threat to oneself or significant others.

  • Stress response: Activation of physiological and psychological mechanisms.

  • Feelings of apprehension: Mental uneasiness and worry.

  • Helplessness: Perceived inability to manage or control the threat.

Anxiety Disorders Overview

Anxiety disorders are marked by excessive distress or fear, often in response to imminent danger (real or perceived). These disorders can impair daily functioning and relationships, but effective treatments are available.

  • Impairment: Untreated anxiety can damage relationships and work ability.

  • Treatment: Many do not realize the severity or recognize symptoms.

Pathophysiology of Anxiety Disorders

Biological and Environmental Factors

Anxiety disorders affect individuals of all ages and may arise from a combination of biological and environmental factors. Free-floating anxiety refers to anxiety not linked to a specific cause.

  • Types: Generalized anxiety disorder (GAD), separation anxiety, panic disorder.

Etiology

The development of anxiety disorders is multifactorial, involving neurobiological, neurochemical, psychosocial, behavioral, and genetic components.

  • Neurobiological: Nervous system abnormalities, especially in the limbic system (thalamus, hypothalamus, amygdala, hippocampus).

  • Neurochemical: Imbalances in neurotransmitters such as serotonin, dopamine, norepinephrine, and GABA.

  • Psychosocial: Life stressors, trauma, and social environment.

  • Behavioral: Learned responses to stress.

  • Genetic: Family history increases risk.

Neurotransmitters Involved

Neurotransmitter

Role in Anxiety

Serotonin

Regulates mood, sleep, and appetite; low levels linked to anxiety and depression.

Dopamine

Involved in pleasure and reward; dysregulation may contribute to anxiety symptoms.

Norepinephrine

Associated with arousal and alertness; excess activity linked to panic and anxiety.

GABA

Main inhibitory neurotransmitter; low levels reduce calming effects, increasing anxiety.

Risk Factors

Contributing Factors

  • Childhood adversity (ACES): Early trauma increases risk.

  • Family history: Genetic predisposition.

  • Social factors: Poor communication, lack of social support.

  • Chronic illness: Ongoing health issues.

  • Traumatic events: Exposure to trauma.

  • Personality traits: Shyness, perfectionism, chronic worry.

  • Multiple stressors: Accumulation of life stressors.

Prevention

Strategies for Prevention

  • Early intervention: Seek help early and monitor patterns of anxiety.

  • Journaling: Catalog stressors and sources of relief.

  • Substance avoidance: Avoid unhealthy substance use, especially for those with multiple risk factors.

Clinical Manifestations

Generalized Anxiety Disorder (GAD)

GAD is characterized by pervasive apprehension and worry, excessive anxiety for at least six months, and symptoms that interfere with daily functioning.

  • Difficulty relaxing, fatigue

  • Poor concentration

  • Irritability

Common Symptoms of GAD

Constant worry

Difficulty sleeping

Exaggerated worry

Muscle tension

Easily startled

Headaches

Panic Disorder

  • Sudden attacks of terror (few minutes to an hour)

  • Fear of unexplained symptoms

  • Intense worry about next attack

  • Cannot be due to substances

Phobias

  • Intense, persistent fear of anxiety associated with a particular object or situation

  • Contact with stressor produces severe panic

  • Three categories: Specific, agoraphobia, social anxiety disorder

Levels of Anxiety

Classification and Manifestations

Level

Manifestations

Mild

Optimal functioning, increased alertness, motivation, restlessness, irritability

Moderate

Narrowed perceptual field, selective inattention, discomfort, irritability, increased heart rate, muscle tension

Severe

Greatly reduced perceptual field, difficulty following directions, dread, horror, headaches, dizziness, insomnia, palpitations

Panic

Disorganized behavior, loss of rational thought, inability to focus, perception distorted, immobility or hyperactivity, incoherence

Treatment and Management

Collaborative Treatment

  • Occurs in home and community settings

  • Based on observation and history

  • No lab tests for diagnosis; tests used to rule out physical illness

  • Referral to mental health professionals

Pharmacological Therapy

  • Antidepressants: SSRIs (escitalopram, fluoxetine, paroxetine, sertraline), SNRIs (duloxetine, venlafaxine)

  • Benzodiazepines: alprazolam, clonazepam, lorazepam, diazepam (short-term use, risk of dependence, monitor for respiratory depression)

  • Antianxiety drugs: Buspirone (requires daily use, takes 2-4 weeks for effect), Meprobamate (side effects: dizziness, drowsiness)

  • MAOIs: infrequently used due to side effects and drug interactions

Nonpharmacologic Therapy

  • Cognitive-behavioral therapy (CBT): Reframing thoughts, effective for all anxiety disorders

  • Herbal preparations: Kava (risk of liver damage), lavender, chamomile

  • Massage and relaxation techniques: Yoga, meditation, TM (transcendental meditation)

Lifespan Considerations

  • Children

  • Adolescents

  • Pregnant women

  • Older adults

  • Adults

Nursing Process

Assessment

  • Health history (illnesses, medications, supplements)

  • Past and present stressors

  • Home and work conditions

  • Socioeconomic status

  • Coping methods

  • Physical assessment

Diagnosis

  • Anxiety

  • Fear

  • Knowledge deficit

  • Ineffective coping

  • Disturbed sleep pattern

  • Impaired social interaction

  • Risk for ineffective self-health management

Planning

  • Decrease in anxiety level

  • Demonstrate effective coping mechanisms

  • Demonstrate relaxation techniques

  • Participate in psychotherapy

Interventions

Level

Interventions

Mild

Recognize triggers, self-management, positive self-talk, muscle relaxation, medication adherence, therapy attendance, community resources

Moderate

Participate in diversional activities, identify stressors, recall successful coping strategies

Severe

Clear communication, administer medications, possible hospitalization

Panic

Active supervision, assistance with basic needs, calm environment, reinforce reality, set safety limits, allow repetitive tasks, administer medications

Evaluation

  • Anxiety diminished

  • Improved coping mechanisms

  • Self-regulation of anxiety response

  • Engagement in healthy behaviors

Pearson Logo

Study Prep